Velicept Therapeutics

OverviewSuggest Edit

Velicept Therapeutics, a clinical development company, develops and commercializes drugs that have the potential to improve patients’ lives by transforming the treatment of overactive bladder (OAB) and irritable bowel syndrome (IBS). Its lead program includes Solabegron, a differentiated and selective compound that relaxes the bladder smooth muscle by stimulating beta 3-adrenoceptors, which is being investigated for OAB and IBS conditions that affect the quality of life.

TypePrivate
Founded2015
HQChesterbrook, US
Websitevelicept.com

Locations

Velicept Therapeutics is headquartered in
Chesterbrook, United States

Location Map

Latest Updates

Employees (est.) (Mar 2020)11

Key People/Management at Velicept Therapeutics

Eliot Ohlstein

Eliot Ohlstein

Chief Scientific Officer
Jill Becker Mast

Jill Becker Mast

Director
James C. Walker

James C. Walker

Chairman and CEO
Clarence Young

Clarence Young

Chief Medical Officer
Doug Gessl

Doug Gessl

Chief Financial Officer
Show more

Velicept Therapeutics Office Locations

Velicept Therapeutics has an office in Chesterbrook
Chesterbrook, US (HQ)
640 Lee Rd #119
Show all (1)

Velicept Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2015

Velicept Therapeutics total Funding

$36 m

Velicept Therapeutics latest funding size

$15 m

Time since last funding

a year ago

Velicept Therapeutics investors

Velicept Therapeutics's latest funding round in October 2018 was reported to be $15 m. In total, Velicept Therapeutics has raised $36 m
Show all financial metrics

Velicept Therapeutics Online and Social Media Presence

Embed Graph

Velicept Therapeutics Frequently Asked Questions

  • When was Velicept Therapeutics founded?

    Velicept Therapeutics was founded in 2015.

  • Who are Velicept Therapeutics key executives?

    Velicept Therapeutics's key executives are Eliot Ohlstein, Jill Becker Mast and James C. Walker.

  • How many employees does Velicept Therapeutics have?

    Velicept Therapeutics has 10 employees.

  • Who are Velicept Therapeutics competitors?

    Competitors of Velicept Therapeutics include Motac Neuroscience, Pharvaris and Probiotical.

  • Where is Velicept Therapeutics headquarters?

    Velicept Therapeutics headquarters is located at 640 Lee Rd #119, Chesterbrook.

  • Where are Velicept Therapeutics offices?

    Velicept Therapeutics has an office in Chesterbrook.

  • How many offices does Velicept Therapeutics have?

    Velicept Therapeutics has 1 office.